Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
Table of contributions for the expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza
The 'Table of contributions' contains all comments received through a public consultation on this topic and lists ECDC’s responses to those comments.
Communicable disease threats report, 6–12 August 2017, week 32
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6–12 August 2017 and includes updates on poliomyelitis, cholera, measles, Legionnaires' disease, West Nile virus, seasonal influenza, and malaria.
Rapid Risk Assessment: Public health risks related to communicable diseases during the Hajj 2017, Saudi Arabia, 30 August – 4 September 2017
This document assesses the potential risk of outbreaks and transmission of communicable diseases during the Hajj taking place between 30 August and 4 September 2017.
ECDC tool for the prioritisation of infectious disease threats
This qualitative tool, implemented as an Excel workbook, ranks infectious disease threats in a transparent, comparable and methodologically reproducible manner.
Communicable disease threats report, 30 July - 5 August, week 31
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 July – 5 August 2017 and includes updates on hepatitis A, West Nile virus, Vibrio, measles, seasonal influenza, MERS, and Legionnaires' disease.